Evidence map›Paper›PMID 41094832›Full record

ArticleSensors (Basel, Switzerland)2025

Deep Learning-Based Assessment of Brainstem Volume Changes in Spinocerebellar Ataxia Type 2 (SCA2): A Study on Patients and Preclinical Subjects.

Robin Cabeza-Ruiz, Luis Velázquez-Pérez, Evelio González-Dalmau, Alejandro Linares-Barranco, Roberto Pérez-Rodríguez

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Robin Cabeza-RuizCenter for CAD/CAM Studies, University of Holguín, Holguín 80100, Cuba.ORCID 0000-0003-4719-8264
Luis Velázquez-PérezCuban Academy of Sciences, Havana 10200, Cuba.ORCID 0000-0003-1628-2703
Evelio González-DalmauCuban Neuroscience Center, Havana 10200, Cuba.ORCID 0000-0003-4569-2103
Alejandro Linares-BarrancoRobotics and Technology of Computers Lab, University of Seville, 41012 Seville, Spain.ORCID 0000-0002-6056-740X
Roberto Pérez-RodríguezCenter for CAD/CAM Studies, University of Holguín, Holguín 80100, Cuba.ORCID 0000-0001-5741-5168

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disorder marked by progressive brainstem and cerebellar atrophy, leading to gait ataxia. Quantifying this atrophy in magnetic resonance imaging (MRI) is critical for tracking disease progression in both symptomatic patients and preclinical subjects. However, manual segmentation of brainstem subregions (mesencephalon, pons, and medulla) is time-consuming and prone to human error. This work presents an automated deep learning framework to assess brainstem atrophy in SCA2. Using T1-weighted MRI scans from patients, preclinical carriers, and healthy controls, a U-shaped convolutional neural network (CNN) was trained to segment brainstem subregions and quantify volume loss. The model achieved strong agreement with manual segmentations, significantly outperforming four U-Net-based benchmarks (mean Dice scores: whole brainstem 0.96 vs. 0.93-0.95, pons 0.96 vs. 0.91-0.94, mesencephalon 0.96 vs. 0.89-0.93, and medulla 0.95 vs. 0.91-0.93). Results revealed severe atrophy in preclinical and symptomatic cohorts, with pons volumes reduced by nearly 50% compared to controls (

Indexed as

Brain StemDeep LearningSpinocerebellar AtaxiasAdultAtrophyFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeural Networks, Computerbrain MRI segmentationbrainstem segmentationconvolutional neural networksdeep learningmedical imaging processingU-Net

Identifiers

PMID41094832
PMCPMC12526562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.